Skip to main content
. 2019 Nov 1;75(1):64–71. doi: 10.1136/thoraxjnl-2018-212675

Table 7.

Total user costs of hospital-based and home-based management during the intensive phase of TB retreatment

Mean cost US dollars (95% CI)
Hospital-based management Home-based management Mean difference*
Patient costs
During admission
 Direct medical† 0.7 (0.2 to 1.2) 0.4 (0.0 to 0.7) 0.3 (−0.2 to 1.0)
 Direct non-medical
  Food 69.8 (58.4 to 81.2) 26.7 (21.5 to 31.8) 43.1 (30.5 to 55.7)
  Transport 3.6 (1.6 to 5.7) 1.6 (0.5 to 2.6) 2.1 (−0.1 to 4.3)
  Linen 0.7 (0.1 to 1.3) 1.1 (−0.1 to 2.3) −0.5 (−1.8 to 0.9)
  Other out of pocket 11.9 (7.1 to 16.7) 4.7 (3.2 to 6.2) 7.2 (2.1 to 12.4)
 Indirect‡ 133.5 (111.6 to 155.4) 37.0 (28.7 to 45.3) 96.5 (73.2 to 119.7)
Health facility post discharge
 Direct medical and non-medical 1.1 (0.3 to 2.0) −1.1 (−2.0 to -0.3)
 Indirect 0.3 (0.1 to 0.5) −0.8 (−1.8 to 0.1)
Total patient costs 220.2 (189.8 to 250.8) 72.9 (60.5 to 85.3) 147.4 (114.1 to 180.6)
Guardian costs
During admission
 Direct non-medical
  Food 17.7 (11.1 to 24.2) 13.6 (9.2 to 17.9) 4.1 (−3.5 to 11.7)
  Transport 10.0 (5.6 to 14.3) 6.4 (4.1 to 8.8) 3.5 (−1.2 to 8.2)
  Linen 0.1 (−0.1 to 0.2) 0.1 (0.0 to 0.3) 0.0 (−0.3 to 0.2)
  Other out of pocket 2.9 (1.1 to 4.7) 1.6 (0.7 to 2.5) 1.3 (−0.7 to 3.4)
 Indirect 20.6 (8.4 to 32.9) 5.2 (2.8 to 7.7) 15.4 (3.1 to 27.7)
Health facility post discharge
 Direct non-medical 1.0 (−0.6 to 2.7) −1.0 (−2.7 to 0.6)
 Indirect 0.8 (−0.1 to 1.8) −0.8 (−1.8 to 0.1)
Total guardian costs 51.3 (31.8 to 70.8) 28.6 (21.5 to 36.2) 22.4 (2.2 to 42.7)
Total user costs 271.6 (234.4 to 308.7) 101.8 (85.1 to 118.4) 169.8 (128.9 to 210.7)

*Bootstrapped estimates of mean differences and 95% CI.

†Drugs and investigations purchased privately if unavailable in the public facility.

‡Lost income.